Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of the axitinib implant (OTX-TKI) for non-proliferative diabetic retinopathy, with recruitment on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• OTX-TKI Axitinib Implant (axitinib)

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 3 | Status: RECRUITING